Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTACEL vs DTaP + Act-HIB in Healthy Infants
NCT01062477Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jan 2010
- Primary completion
- Sep 2011
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Actacel in diphtheria, Tetanus, pertussis, Haemophilus influenzae type b infection (Hib), sponsored by Sanofi. Started Jan 2010; status: completed.
02
Drugs
Actacel
03
Conditions
diphtheriaTetanuspertussisHaemophilus influenzae type b infection (Hib)
Beyond the preview
Go deeper on NCT01062477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01062477.